Literature DB >> 11061637

An overview of the global HIV/AIDS epidemic, with a focus on the United States.

H Gayle1.   

Abstract

The HIV/AIDS epidemic is a global human tragedy, especially in sub-Saharan Africa. The pandemic affects people in the primer of their lives moving from at-risk populations to broader cross-sections of society. There have been more than 47 million adults and children infected since the beginning of the epidemic, and more than 18.8 million people have died. Over 95% of the global total of all AIDS cases are in the developing world, with prevalence among adults at less than 1% in India and Europe, to more than 10% in several African countries. The overwhelming majority of all infections globally are acquired through unprotected sexual intercourse, with at least 70% resulting from heterosexual intercourse. There have been more than 733,374 AIDS cases reported to the Centers for Disease Control and Prevention (CDC) in the US since the beginning of the epidemic, and more than 430,000 deaths. The largest number and proportion of AIDS cases reported have occurred among gay and bisexual men. This trend continues today, although racial and ethnic minorities, women, and youth are becoming infected in increasing proportions. The south has the most people living with AIDS, followed by the north-east. The global situation is improving in some areas, but even if all HIV transmission could be completely stopped tomorrow, the long-term health, social and economic consequences will be devastating well into the 21st century. The magnitude of the epidemic and the continuing explosive risk of infection, coupled with the economic and infrastructural realities of the regions of the world, make prevention the only realistic approach.

Entities:  

Mesh:

Year:  2000        PMID: 11061637

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  11 in total

1.  Governments as facilitators or obstacles in the HIV epidemic.

Authors:  Arthur J Ammann; Susie Nogueira
Journal:  BMJ       Date:  2002-01-26

Review 2.  Female-initiated barrier methods for the prevention of STI/HIV: where are we now? Where should we go?

Authors:  M Latka
Journal:  J Urban Health       Date:  2001-12       Impact factor: 3.671

3.  Preventing HIV.

Authors:  Arthur J Ammann
Journal:  BMJ       Date:  2003-06-21

4.  HIV related behaviours and attitudes among Chinese men who have sex with men in Hong Kong: a population based study.

Authors:  J T F Lau; J H Kim; M Lau; H-Y Tsui
Journal:  Sex Transm Infect       Date:  2004-12       Impact factor: 3.519

5.  Association of human papillomavirus-related knowledge, attitudes, and beliefs with HIV status: a national study of gay men.

Authors:  Paul A Gilbert; Noel T Brewer; Paul L Reiter
Journal:  J Low Genit Tract Dis       Date:  2011-04       Impact factor: 1.925

6.  Neuropsychological Dysfunction among HIV Infected Drug Abusers.

Authors:  Ramani S Durvasula; Charles H Hinkin
Journal:  Am J Infect Dis       Date:  2006

Review 7.  Drug interactions between antiretroviral medications and medications used in the treatment of drug addiction: research needs.

Authors:  Jag H Khalsa; Ahmed Elkashef
Journal:  Am J Addict       Date:  2010 Jan-Feb

8.  Rhesus macaque model of chronic opiate dependence and neuro-AIDS: longitudinal assessment of auditory brainstem responses and visual evoked potentials.

Authors:  Mariam Riazi; Joanne K Marcario; Frank K Samson; Himanshu Kenjale; Istvan Adany; Vincent Staggs; Emily Ledford; Janet Marquis; Opendra Narayan; Paul D Cheney
Journal:  J Neuroimmune Pharmacol       Date:  2009-03-13       Impact factor: 4.147

Review 9.  Medical consequences of drug abuse and co-occurring infections: research at the National Institute on Drug Abuse.

Authors:  Jag H Khalsa; Glenn Treisman; Elinore McCance-Katz; Ellen Tedaldi
Journal:  Subst Abus       Date:  2008       Impact factor: 3.716

10.  The interaction of sexual identity with sexual behavior and its influence on HIV risk among latino men: results of a community survey in northern San Diego County, California.

Authors:  Jennifer A Zellner; Ana P Martínez-Donate; Fernando Sañudo; Araceli Fernández-Cerdeño; Carol L Sipan; Melbourne F Hovell; Héctor Carrillo
Journal:  Am J Public Health       Date:  2008-11-13       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.